SB-366791

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
SB-366791
SB-366791 structure.png
Identifiers
  • (E)-3-(4-chlorophenyl)-N-(3-methoxyphenyl)prop-2-enamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC16H14ClNO2
Molar mass287.74 g·mol−1
3D model (JSmol)
  • COC1=CC=CC(=C1)NC(=O)/C=C/C2=CC=C(C=C2)Cl
  • InChI=1S/C16H14ClNO2/c1-20-15-4-2-3-14(11-15)18-16(19)10-7-12-5-8-13(17)9-6-12/h2-11H,1H3,(H,18,19)/b10-7+
  • Key:RYAMDQKWNKKFHD-JXMROGBWSA-N

SB-366791 is a drug which acts as a potent and selective blocker of the TRPV1 ion channel. It has analgesic effects in animal studies, and is used in research into pain and inflammation.[1][2][3]

See also[edit]

References[edit]

  1. ^ Dell H (December 2003). "New compound fires up pain research". Drug Discovery Today. 8 (23): 1053. doi:10.1016/s1359-6446(03)02928-3. PMID 14693457.
  2. ^ Ma SX, Kim HC, Lee SY, Jang CG (December 2018). "TRPV1 modulates morphine self-administration via activation of the CaMKII-CREB pathway in the nucleus accumbens". Neurochemistry International. 121: 1–7. doi:10.1016/j.neuint.2018.10.009. PMID 30292787. S2CID 52929149.
  3. ^ Uchytilova E, Spicarova D, Palecek J (April 2021). "Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist". International Journal of Molecular Sciences. 22 (7): 3712. doi:10.3390/ijms22073712. PMC 8038144. PMID 33918267.